Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
In the last decade, it has become apparent that Toll-like Receptor (TLR) signaling can play an important role in ovarian cancer progression. Interestingly, TLR activation in immune cells can help activate an anti-tumor response, while TLR signaling in tumor cells themselves is often associated with...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2014-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00341/full |